Prosecution Insights
Last updated: October 04, 2026

Ultima Genomics Inc.

Technology area: Biotechnology & Pharmaceuticals

12 pending office actions • 3 art units • 11 examiners • 0 of 12 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Portfolio Summary

12
Total Pending OAs
10
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (42%)
7
Medium (58%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (8%)
§103 only5 (42%)
§102 only1 (8%)
Double-patenting + other1 (8%)
Multi-statute (no §101)4 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
42% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
7
Business / Other
58% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TURPIN, ZACHARY MARK 2 4.0% -5.0%
FOX, DANIELLE A 1 83.3% +13.1%
RILEY, JEZIA 1 82.9% +7.3%
WILDER, CYNTHIA B 1 71.0% +26.6%
EIX, EMILY FAY 1 45.5% +78.3%
SINES, BRIAN J 1 80.1% +5.2%
HORLICK, KENNETH R 1 78.9% +15.3%
BENZION, GARY 1 21.1% +13.7%
OLSON, ALEXANDRA NADINE 1 100.0% +0.0%
GREENE, CAROLYN LEE 1 65.3% +47.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19198945 METHODS AND SYSTEMS FOR COUNTER SCAN AREA MODE IMAGING FOX, DANIELLE A —
18488731 SYSTEMS AND METHODS FOR SPATIAL REFERENCE SEQUENCING OLSON, ALEXANDRA NADINE —

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18281930 METHODS FOR SEQUENCING NUCLEIC ACID MOLECULES WITH SEQUENTIAL BARCODES TURPIN, ZACHARY MARK 31d overdue
18776428 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING RILEY, JEZIA —
18651565 NUCLEIC ACID POLYMERASE FOR INCORPORATING LABELED NUCLEOTIDES EIX, EMILY FAY —
18623877 ENHANCED RESOLUTION IMAGING SINES, BRIAN J —
18540604 METHODS FOR PREPARING CAPTURE SUBSTRATES BENZION, GARY —
18475532 BENIGN SCAR-FORMING CLEAVABLE LINKERS GREENE, CAROLYN LEE —
18025603 METHODS AND SYSTEMS FOR SEQUENCE AND VARIANT CALLING FONSECA LOPEZ, FRANCINI ALVARENGA —
18114091 METHODS AND SYSTEMS FOR REDUCING PARTICLE AGGREGATION TURPIN, ZACHARY MARK —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
19198945 METHODS AND SYSTEMS FOR COUNTER SCAN AREA MODE IMAGING FOX, DANIELLE A —
18763834 USE OF ETHYLENE CARBONATE IN NUCLEIC ACID SEQUENCING METHODS WILDER, CYNTHIA B —
18651565 NUCLEIC ACID POLYMERASE FOR INCORPORATING LABELED NUCLEOTIDES EIX, EMILY FAY —
18435829 SYSTEMS AND METHODS FOR SAMPLE PREPARATION FOR SEQUENCING HORLICK, KENNETH R —
18540604 METHODS FOR PREPARING CAPTURE SUBSTRATES BENZION, GARY —
18475532 BENIGN SCAR-FORMING CLEAVABLE LINKERS GREENE, CAROLYN LEE —

Top Art Units

Art UnitApps
1681 2
1682 2
1653 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19198945 METHODS AND SYSTEMS FOR COUNTER SCAN AREA MODE IMAGING FOX, DANIELLE A — §102 Non-Final OA — Pending May 05, 2025
18776428 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING RILEY, JEZIA — §102§103Other Non-Final OA — Pending Jul 18, 2024
18763834 USE OF ETHYLENE CARBONATE IN NUCLEIC ACID SEQUENCING METHODS WILDER, CYNTHIA B — §103 Non-Final OA — Pending Jul 03, 2024
18651565 NUCLEIC ACID POLYMERASE FOR INCORPORATING LABELED NUCLEOTIDES EIX, EMILY FAY 1653 §102§103 Non-Final OA — Pending Apr 30, 2024
18623877 ENHANCED RESOLUTION IMAGING SINES, BRIAN J — §102§103 Non-Final OA — Pending Apr 01, 2024
18435829 SYSTEMS AND METHODS FOR SAMPLE PREPARATION FOR SEQUENCING HORLICK, KENNETH R — §112DP Non-Final OA — Pending Feb 07, 2024
18540604 METHODS FOR PREPARING CAPTURE SUBSTRATES BENZION, GARY 1681 §103 Non-Final OA — Pending Dec 14, 2023
18488731 SYSTEMS AND METHODS FOR SPATIAL REFERENCE SEQUENCING OLSON, ALEXANDRA NADINE — §103 Non-Final OA — Pending Oct 17, 2023
18475532 BENIGN SCAR-FORMING CLEAVABLE LINKERS GREENE, CAROLYN LEE 1681 §102§103§112 Non-Final OA — Pending Sep 27, 2023
18281930 METHODS FOR SEQUENCING NUCLEIC ACID MOLECULES WITH SEQUENTIAL BARCODES TURPIN, ZACHARY MARK 1682 §103 Final Rejection 31d overdue Pending Sep 13, 2023
18025603 METHODS AND SYSTEMS FOR SEQUENCE AND VARIANT CALLING FONSECA LOPEZ, FRANCINI ALVARENGA — §101§102§103§112 Non-Final OA — Pending Mar 09, 2023
18114091 METHODS AND SYSTEMS FOR REDUCING PARTICLE AGGREGATION TURPIN, ZACHARY MARK 1682 §103 Final Rejection — Pending Feb 24, 2023

Managing Ultima Genomics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month